The conceptual 'Jelly' medicine has been designed as a healthcare solution for developing nations to help offer an alternative way to take essential medication.
The medication is encased in a jelly-like substance that can be easily consumed by the patient without water to make it ideal for areas where drinking water is scarce or contaminated. This could drastically reduce the instance of disease and death in areas that are hardest hit to support better health amongst those who need the most support.
The conceptual 'Jelly' medicine is the design work of Jeongho Oh, Dongho Choi and Ryangtak Oh, and is the winner of the iF Talent Design Award and has been certified as an internationally beneficial design that could transform healthcare.
Waterless Jelly-Encased Medications
The Conceptual 'Jelly' Medicine Doesn't Require a Glass of H2O
Trend Themes
1. Waterless Medications - The use of jelly-like substances to encase medications for consumption without the need for water, creating opportunities for healthcare innovations in developing nations and areas with limited access to clean water.
2. Alternative Medicine Consumption - The development of new, innovative ways to consume medications, such as through jelly-based substances, creating opportunities to improve medication adherence and effectiveness.
3. International Healthcare Design - The creation of healthcare solutions tailored to the specific needs of developing nations, which consider their unique challenges, creating opportunities for disruptive innovation in healthcare design and delivery.
Industry Implications
1. Pharmaceutical - The development of new technologies for medication delivery, including jelly-based substances, that increase medication adherence and improve patient outcomes.
2. Public Health - The use of innovative medication delivery methods, such as jelly-encased medications, to improve public health in areas with limited access to clean water or limited resources for healthcare delivery.
3. Medical Device - The development of new medical devices for delivering medications, including those encased in jelly-like substances, which offer new opportunities for improving healthcare delivery and outcomes.